Charles River Laboratories (CRL) Tops Q3 EPS by 15c
Tweet
Share
E-mailGet Alerts CRL Hot Sheet
Price: $230.69 +0.70%
Revenue Growth %: -5.1%
Financial Fact:
Provision (benefit) for income taxes: 15.57M
Today's EPS Names:
CRMT, More
Revenue Growth %: -5.1%
Financial Fact:
Provision (benefit) for income taxes: 15.57M
Today's EPS Names:
CRMT, More
Join SI Premium – FREE
Charles River Laboratories (NYSE: CRL) reported Q3 EPS of $1.53, $0.15 better than the analyst estimate of $1.38. Revenue for the quarter came in at $585.3 million versus the consensus estimate of $567.79 million.
GUIDANCE:
Charles River Laboratories sees FY2018 EPS of $5.87-$5.97, versus the consensus of $5.92.
For earnings history and earnings-related data on Charles River Laboratories (CRL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump said he was unaware of his earnings from crypto
- Constellation Brands (STZ) Tops Q1 EPS by 18c
- FactSet (FDS) Tops Q3 EPS by 8c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
